Help control your eye pressure and possibly reduce your need for medication with the Hydrus Microstent
Roughly the size of an eyelash, the highly flexible Hydrus Microstent is placed by a doctor using microscopic incisions and advanced equipment. This less invasive approach allows for fewer complications and faster healing times than traditional glaucoma surgery.
Rounded distal tip for a smooth passage into Schlemm’s canal
Open scaffold design provides outflow pathways for aqueous
Aqueous inlet facilitating flow from anterior chamber to Schlemm’s canal
Setting new standards in glaucoma treatment
lvantis, Inc. is a company committed to expanding patient treatment and improving outcomes through innovative minimally invasive glaucoma surgical (MIGS) solutions, the fastest growing segment of the ophthalmology market.
Offering next-generation MIGS technology that addresses unmet needs in the global glaucoma market.
Improved patient experience
Committed to improving glaucoma patient outcomes using evidence-based research.
Unparalleled clinical data
Collaborating with clinical experts to generate unequivocal clinical evidence through precisely designed, ANSI standard clinical trials.
Using a gonioprism, the Hydrus Microstent is inserted through a clear corneal incision and guided through the trabecular meshwork into Schlemm’s canal.
Once in position, the Hydrus Microstent is advanced until the device has scaffolded approximately 90° of the canal, ensuring access to collector channels.